It's worth taking note when returns accelerate, as it can indicate positive change in the underlying business, and winners often keep winning. Shareholders are doubtless excited that the stock price has been doing even better lately, with a gain of 57% in just ninety days. While it's always nice to make a profit on the stock market, we do note that the TSR was no better than the broader market return of about 37%. We're happy to report that RAPT Therapeutics are up 33% over the year. If you are thinking of buying or selling RAPT Therapeutics stock, you should check out this free report showing analyst profit forecasts. Even so, future earnings will be far more important to whether current shareholders make money. We consider it positive that insiders have made significant purchases in the last year.
0 kommentar(er)
